Workflow
Anixa Biosciences(ANIX)
icon
Search documents
Anixa Biosciences(ANIX) - 2019 Q3 - Quarterly Report
2019-09-06 21:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2019 Commission file number 0-11254 ANIXA BIOSCIENCES, INC. | --- | --- | --- | |-------------------------------------------------|--------------------------------------------------------|-----------------------------| | | (Exact name of registrant as specified in its charter) | | | Delaware (State or ...
Anixa Biosciences(ANIX) - 2019 Q2 - Quarterly Report
2019-06-11 21:51
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2019 Commission file number 0-11254 | --- | --- | --- | |------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------|-----------------------------------------------------| | Delaware ...
Anixa Biosciences(ANIX) - 2019 Q1 - Quarterly Report
2019-03-13 20:29
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q quarterly report pursuant to section 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2019 Commission file number 0-11254 ANIXA BIOSCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware 11-2622630 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 3150 Almaden Expressway, Suite 250 San Jose, CA 95118 (Address o ...
Anixa Biosciences, Inc. (ANIX) CEO Amit Kumar on Outlook for 2019 Transcript
2019-01-25 03:11
Anixa Biosciences, Inc. (NASDAQ:ANIX) Outlook for 2019 January 24, 2019 4:30 PM ET Company Participants Amit Kumar - Chairman, President and CEO Mike Catelani - COO and CFO Lewis Titterton - Lead Independent Director Conference Call Participants Jason Kolbert - Dawson James Andrew D'silva - B. Riley FBR Stephen Dunn - LifeTech Capital Daniel Carlson - Tailwinds Research Operator Good day everyone and welcome to today's Anixa Biosciences 2019 Outlook. At this time all participants are only in a listen-only m ...
Anixa Biosciences(ANIX) - 2018 Q4 - Annual Report
2019-01-11 21:31
| --- | --- | --- | |------------|-----------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | UNITED SECURITIES AND EXCHANGE WASHINGTON, D.C. ...